Recent PCRX News
- Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024 • GlobeNewswire Inc. • 10/30/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2024 10:54:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2024 12:04:39 PM
- Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer • GlobeNewswire Inc. • 10/21/2024 12:00:00 PM
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) • GlobeNewswire Inc. • 10/07/2024 12:00:00 PM
- Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025 • GlobeNewswire Inc. • 10/03/2024 12:00:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 12:02:24 PM
- Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee • GlobeNewswire Inc. • 09/26/2024 12:00:00 PM
- DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders • PR Newswire (US) • 09/25/2024 12:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/14/2024 12:29:20 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 02:17:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:02:50 PM
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) • GlobeNewswire Inc. • 09/09/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 12:25:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:35:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:55:05 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 08/13/2024 12:43:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 12:33:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 12:33:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 07:23:04 PM
- Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey • GlobeNewswire Inc. • 08/09/2024 07:21:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 10:00:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/02/2024 02:09:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/30/2024 08:02:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:01:24 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM